The American Society of Clinical Oncology (ASCO) 2017 Annual Meeting was held June 2-6 in Chicago, and included a session dedicated to oral abstracts in gynecologic oncology. Several SGO members were on hand to discuss their impressions of selected abstracts, including two international ovarian cancer surgery trials, the ICON6 ovarian cancer trial, the CheckMate 358 nivolumab trial, and two endometrial cancer trials, including PORTEC-3.